Saliba, R. M., Miatech, J., Ramdial, J., Rondon, G., Alatrash, G., Alousi, A., Bashir, Q., Chen, G., Fingrut, W., Hosing, C., Kebriaei, P., Khouri, I., Marin, D., Nieto, Y., Olson, A., Oran, B., Popat, U., Qazilbash, M., Smallbone, P., Srour, S., Tanner, M., Rezvani, K., Champlin, R., Shpall, E., Mehta, R. (2025). MMF is associated with higher non-relapse mortality and inferior survival in AML/MDS patients receiving peripheral blood matched allogeneic stem cell transplantation with post-transplant cyclophosphamide based gvhd prophylaxis. Blood. https://doi.org/10.1182/blood-2025-5996